| Salmonella selective enrichment medium containing tetrathionate and magnesium salt -> Monitor Keywords |
|
|
 
Salmonella selective enrichment medium containing tetrathionate and magnesium saltSalmonella selective enrichment medium containing tetrathionate and magnesium salt description/claimsThe Patent Description & Claims data below is from USPTO Patent Application 20080096195, Salmonella selective enrichment medium containing tetrathionate and magnesium salt. Brief Patent Description - Full Patent Description - Patent Application Claims
[0001]The present invention relates to a salmonella selective enrichment medium containing tetrathionate or a salt thereof and at least one magnesium salt, as well as a method for detecting salmonella in a sample by using said selective enrichment medium. [0002]Salmonella are at the origin of animal diseases that can be transmitted to man, notably through the food supply, and whose development can cause pathogenic effects. They have long been recognized as sources of foodborne illnesses. Their detection is thus very important, in particular with respect to water monitoring in the food industry, as well as in the field of medicine. Various methods are capable of detecting the presence of salmonella in a suspect sample. Some of these methods include a step of growing the possibly present salmonella by placing said sample in contact with a salmonella specific enrichment medium. [0003]Liquid, semi-solid or solid enrichment media inoculated with a polymicrobial product that contains salmonella make it possible to increase the growth and proportion of salmonella and then to detect them in a sample. [0004]For many years, three enrichment media formula families have been widely used that contain, as a selective agent, either selenite (since 1936), or tetrathionate, optionally made extemporaneously from thiosulfate and an iodo-iodide solution (since 1923), or a high-concentration magnesium salt (since 1956). [0005]However, the salmonella enrichment media available on the market have variable effectiveness depending on various factors such as the strains to detect, the type of sample or the competitive flora found in the samples. [0006]Furthermore, one of the principal areas of technological research and development relates to salmonella detection speed. Thus, the most recent techniques involving "DNA chips" not only make it possible to carry out presence/absence tests but also to quantify the bacteria possibly present. However, such techniques are complex to implement, costly and do not indicate the viability of the bacteria. This leads to additional detection time. [0007]Thus, currently there is a need for a salmonella detection technique that is effective, whose effectiveness does not vary depending on various factors, and that rapidly detects living salmonella. [0008]In a surprising and unexpected way, the inventor has demonstrated that two salmonella selective agents, namely tetrathionate and a magnesium salt, are compatible with each other in such a way that they can be combined to obtain an effective and robust enrichment medium with improved performance compared to conventional selective medium enrichment methods. [0009]In addition, the method described also has the advantage that the total time required to indicate the presence or absence of salmonella in the sample tested can be reduced to a maximum of 44 hours, whereas traditional methods require an initial period of 48 hours (24 hours of culture in a reactivation medium then 24 hours of culture in a selective medium) before an isolation step on a selective medium (18-24 hours), which is a total of 66 to 72 hours. [0010]Thus, the present invention relates to a salmonella selective enrichment medium wherein said medium is comprised of tetrathionate or a salt thereof and at least one magnesium salt. [0011]In the enrichment medium of the invention, the magnesium salt is used at a concentration sufficient to create high osmotic pressure in said medium. Thus, all other compounds having a similar effect on osmotic pressure in an aqueous medium may also be used to replace or to supplement said magnesium salt. [0012]According to a preferred embodiment of the present invention, said magnesium salt is present in the enrichment medium of the invention at a concentration between 0.1 g/l and 50 g/l, preferably between 2 g/l and 40 g/l and more preferentially still between 7 g/l and 35 g/l. [0013]The magnesium salt is preferably selected among magnesium carbonate, magnesium chloride or magnesium sulfate. [0014]According to a preferred embodiment of the present invention, tetrathionate or a salt thereof is present in the enrichment medium of the invention at a concentration between 0.1 g/l and 40 g/l, preferably between 0.5 g/l and 30 g/l and more preferentially still between 1 g/l and 25 g/l. [0015]The tetrathionate salt is preferably selected among potassium tetrathionate and sodium tetrathionate, regardless of the magnesium salt used. [0016]The present invention also relates to a method for detecting salmonella in a sample comprising the following steps: [0017]salmonella reactivation by incubating said sample in a reactivation broth, [0018]salmonella enrichment by incubating an aliquot of the reactivation medium in a salmonella selective enrichment medium, and [0019]salmonella isolation,wherein the selective enrichment medium used for the enrichment step is such as defined according to the present invention. [0020]The reactivation (or pre-enrichment) step is the step that allows the growth and multiplication of the salmonella, including those in dormancy. This step also makes it possible for stressed bacteria to recover their stability. [0021]Within the framework of the salmonella detection method of the present invention, the duration of this step is considerably reduced (approximately 4 hours according to the invention, compared to approximately 24 hours according to the prior art) because of the quality of the subsequent enrichment step. Indeed, the enrichment medium of the invention makes it possible to enrich salmonella in the reactivation medium in such a way that the reactivation step does not need to be carried out for more than approximately 4 hours in order for it to play its part fully. [0022]It should to be stressed that this reactivation step is in no way obligatory and thus is optional within the framework of the present invention. It is, however, particularly advantageous when the method of the invention is implemented in the food industry because the nature of food safety requires reliable detection of any salmonella possibly present in the sample tested, including salmonella in dormancy. [0023]The salmonella isolation step is carried out in a conventional way well known to those skilled in the art. Considering the high concentration of salmonella obtained in the medium following the enrichment step, this isolation step does not need to be selective (i.e., make it possible to detect salmonella with respect to other bacteria) and can be specific for salmonella alone. [0024]This isolation step can be carried out by immunological methods or PCR, for example, but also by highly specific methods such as those carried out on agar media for salmonella detection (Hektoen agar, etc.). [0025]In a specific embodiment of said method, the isolation step includes an analysis procedure chosen from the group consisting in enzymatic immunological analyses; nucleic acid probe hybridization analyses; pure culture analyses; analyses using biochemical indicators, in particular those developed by calorimetric methods; and immunoimmobilization analyses. The technique can be cited as an example of an isolation analysis. [0026]The method according to the present invention can be used to test food and beverage samples; environmental samples of solids, liquids, such as water, or air; or clinical samples. [0027]The invention is not only limited to the description above and the example below is given only for purposes of illustration. Continue reading about Salmonella selective enrichment medium containing tetrathionate and magnesium salt... Full patent description for Salmonella selective enrichment medium containing tetrathionate and magnesium salt Brief Patent Description - Full Patent Description - Patent Application Claims Click on the above for other options relating to this Salmonella selective enrichment medium containing tetrathionate and magnesium salt patent application. Patent Applications in related categories: 20090291445 - Biomarker of lung injury and repair - The present invention resides in the discovery that circulating cytokaretin 5 (CK5) mRNA level correlates with the presence of a lung injury or disease as well as the severity or stage of the injury or disease. Diagnostic methods and kits are provided. ... 20090291450 - Caterpiller gene family - The present invention relates to a new family of structurally and functionally related nucleic acids and proteins, designed the CATERPILLER family, which is characterized by landmark structural motifs including a nucleotide binding domain and leucine-rich repeat domains. ... 20090291431 - Compositions and methods to detect legionella pneumophila nucleic acid - Compositions are disclosed as nucleic acid sequences that may be used as amplification oligomers, including primers, capture probes for sample preparation, and detection probes specific for Legionella pneumophila 16S or 23S rRNA sequences or DNA encoding 16S or 23S rRNA. Methods are disclosed for detecting the presence of L. pnuemophila ... 20090291433 - Droplet-based nucleic acid amplification method and apparatus - The present invention relates to a droplet-based nucleic acid amplification method and apparatus. According to one embodiment, a method of amplifying a nucleic acid in a biological sample is provided, wherein the method includes: (a) providing a system comprising a droplet microactuator electronically coupled to and controlled by a processor ... 20090291434 - Gene expression markers for colorectal cancer prognosis - A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject. ... 20090291432 - Genetic profiles associated with the 957c>t polymorphism in the drd2 gene - The present invention relates to a method for profiling an individual or group of individuals with respect to a neurological, psychiatric or psychological condition, phenotype or state, including a sub-threshold neurological, psychiatric or psychological condition, phenotype or state. More particularly, the present invention identifies a genetic profile associated with the ... 20090291442 - Hspa1a as a marker for sensitivity to ksp inhibitors - The present invention relates to methods for predicting a response to treatment with a kinesin spindle protein inhibitor using heat shock protein 70, isoform A1a, also known as HSPA1a, as a marker for sensitivity to the kinesin spindle protein (KSP) inhibitors. Method are provided for predicting a response to treatment ... 20090291449 - Method and apparatus to minimize diagnostic and other errors due to transposition of biological specimens among subjects - A method and apparatus for minimizing diagnostic errors due to transposition of biological specimens among subjects provides for independent biometric confirmation that a given specimen is from a given donor. In certain embodiments, a biological specimen confirmation kit comprises a portable and openable case housing components of the kit, at ... 20090291446 - Method for confirming the presence of an analyte - The invention provides methods and kits for the rapid confirmation of an initial analyte test result. In a preferred embodiment, the process confirms the presence of a given microbial target in a mixed culture, or a mixed enrichment media, even when the competing organisms in the mix belong to related ... 20090291440 - Method for synthesizing nucleic acid using dna polymerase beta and single molecule sequencing method - The present invention provides a nucleic acid synthesis method capable of continuously carrying out an extension reaction and a single molecule sequencing method capable of obtaining base information accurately at high speed. A method for synthesizing a nucleic acid, including the steps of: forming a complex of a target nucleic ... 20090291447 - Method of detecting colon cancer marker - It is intended to provide a non-invasive and convenient method of detecting a tumor marker for diagnosing colon cancer which is superior in sensitivity and specificity to the existing fecal occult blood test. More specifically speaking, a method of detecting a tumor marker for diagnosing colon cancer which comprises collecting ... 20090291444 - Methods and materials for detecting and treating dementia - This document relates to methods and materials involved in detecting mutations linked to dementia (e.g., frontotemporal lobar degeneration). For example, methods and materials for determining whether or not a mammal is homozygous for a mutant T allele of rs5848 are provided. This document also relates to methods and materials involved ... 20090291451 - Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome - The present invention provides assays and kits for diagnosing idiopathic congenital central hypoventilation syndrome. The present assays and kits focus on the second polyalanine repeat of the PHOX2b gene or gene product, which is normally 20 residues in length. A polyalanine repeat 25 to 33 residues in length is strongly ... 20090291438 - Methods for analysis of extracelluar rna species - The invention provides methods and kits for enabling quantitative or qualitative analysis of extracellular RNA species in non-cellular bodily fluids including plasma and serum to detect, infer, evaluate, or monitor cancer and other neoplasia or other diseases of interest. ... 20090291436 - Methods for detecting nucleic acids indicative of cancer - The invention provides methods for screening tissue or body fluid samples for nucleic acid indicia of cancer or precancer. ... 20090291437 - Methods for targeting quadruplex sequences - Provided are quadruplex nucleotide sequences and methods for identifying interacting molecules. ... 20090291452 - Micro-rna profiles associated with endometrial cancer development and response to cisplatin and doxorubicin chemotherapy - A method predicting of cancer chemoresponse of the population of cancer cells to the one or more chemotherapeutic agents. Our ability to treat patients with advanced stage and recurrent endometrial cancer is hampered by an incomplete understanding of the molecular basis of disease development and response to therapy. A novel ... 20090291439 - Phosphatases involved in the regulation of cardiomyocyte differentiation - (C) an amino acid sequence having at least 60% or more homology to the amino acid sequence of SEQ ID NO:2 and having cysteine at position 138, wherein a protein consisting of the amino acid sequence has a dual specificity phosphatase activity. (B) an amino acid sequence wherein one or several ... 20090291441 - Polypeptide, nucleic acid molecule encoding it and their uses - A polypeptide containing epitope of the amino acid sequence shown in SEQ ID NO:3 is provided, which is selected from the amino acid sequence of SEQ ID NO:3 and amino acids at 16-32 positions, amino acids at 1-30 positions, amino acids at 50-80 positions and amino acids at 17-200 positions ... 20090291448 - Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy - The application provides methods of prognosing and classifying lung cancer patients into poor survival groups or good survival groups and for determining the benefit of adjuvant chemotherapy by way of a multigene signature. The application also includes kits and computer products for use in the methods of the application. ... 20090291435 - Thermal reaction device and method for using the same - Devices and methods for performing the relative concentration of a target in a sample, the sample containing both target and non-target components, the method performed by partitioning the sample into a large number of reaction volumes such that the target is concentrated relative to the non-target, and performing a detection ... 20090291443 - Use of highly parallel snp genotyping for fetal diagnosis - The present invention provides apparatus and methods for enriching components or cells from a sample and conducting genetic analysis, such as SNP genotyping to provide diagnostic results for fetal disorders or conditions. ... ###  How KEYWORD MONITOR works... a FREE service from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Salmonella selective enrichment medium containing tetrathionate and magnesium salt or other areas of interest. ### Previous Patent Application: Nucleic acid amplification assay and arrangement therefor Next Patent Application: Biological molecule-immobilized chip and its use Industry Class: Chemistry: molecular biology and microbiology ### FreshPatents.com Support Thank you for viewing the Salmonella selective enrichment medium containing tetrathionate and magnesium salt patent info. IP-related news and info Results in 0.18899 seconds Other interesting Feshpatents.com categories: Electronics: Semiconductor , Audio , Illumination , Connectors , Crypto , 174 |
 * Protect your Inventions * US Patent Office filing 
PATENT INFO |
|
